Oak Family Advisors, LLC Astrazeneca PLC Transaction History

Oak Family Advisors, LLC

$370 Million
Q3 2025

A detailed history of Oak Family Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Oak Family Advisors, LLC holds 145,272 shares of AZN stock, worth $12 Million. This represents 3.01% of its overall portfolio holdings.

Number of Shares

145,272

Previous 168,514 13.79%

Holding current value

$12 Million

Previous $11.8 Million 5.35%

% of portfolio

3.01%

Previous 3.98%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 23, 2025	SELL	$68.72 - $82.11 $1.6 Million - $1.91 Million	-23,242 Reduced 13.79%	145,272 $11.1 Million
Q2 2025 Jul 17, 2025	SELL	$64.87 - $75.0 $922,970 - $1.07 Million	-14,228 Reduced 7.79%	168,514 $11.8 Million
Q1 2025 Apr 15, 2025	SELL	$65.37 - $77.96 $984,537 - $1.17 Million	-15,061 Reduced 7.61%	182,742 $13.4 Million
Q4 2024 Jan 24, 2025	BUY	$63.2 - $79.58 $3.72 Million - $4.68 Million	58,833 Added 42.34%	197,803 $13 Million
Q3 2024 Oct 17, 2024	SELL	$76.67 - $87.62 $222,343 - $254,098	-2,900 Reduced 2.04%	138,970 $10.8 Million
Q2 2024 Jul 23, 2024	BUY	$66.81 - $80.83 $183,326 - $221,797	2,744 Added 1.97%	141,870 $11.1 Million
Q1 2024 Apr 24, 2024	BUY	$61.03 - $69.57 $536,331 - $611,381	8,788 Added 6.74%	139,126 $9.43 Million
Q4 2023 Jan 30, 2024	SELL	$61.89 - $69.28 $274,110 - $306,841	-4,429 Reduced 3.29%	130,338 $8.78 Million
Q3 2023 Oct 20, 2023	BUY	$64.85 - $71.7 $657,449 - $726,894	10,138 Added 8.13%	134,767 $9.13 Million
Q2 2023 Aug 02, 2023	SELL	$69.91 - $75.81 $1.02 Million - $1.11 Million	-14,582 Reduced 10.47%	124,629 $8.92 Million
Q1 2023 May 01, 2023	SELL	$63.15 - $71.6 $667,684 - $757,026	-10,573 Reduced 7.06%	139,211 $9.66 Million
Q4 2022 Jan 27, 2023	BUY	$54.21 - $70.44 $502,580 - $653,049	9,271 Added 6.6%	149,784 $0
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $973,235 - $2.49 Million	18,356 Added 15.03%	140,513 $7.71 Million
Q2 2022 Jul 29, 2022	SELL	$59.26 - $71.14 $318,048 - $381,808	-5,367 Reduced 4.21%	122,157 $8.07 Million
Q1 2022 May 03, 2022	BUY	$55.72 - $67.12 $1.38 Million - $1.66 Million	24,704 Added 24.03%	127,524 $8.46 Million
Q4 2021 Feb 02, 2022	BUY	$54.02 - $63.83 $528,261 - $624,193	9,779 Added 10.51%	102,820 $5.99 Million
Q3 2021 Nov 10, 2021	BUY	$55.56 - $60.79 $1 Million - $1.1 Million	18,079 Added 24.12%	93,041 $5.59 Million
Q2 2021 Jul 29, 2021	BUY	$48.42 - $60.18 $470,545 - $584,829	9,718 Added 14.89%	74,962 $4.49 Million
Q1 2021 May 05, 2021	BUY	$47.16 - $54.44 $1.4 Million - $1.62 Million	29,722 Added 83.67%	65,244 $3.24 Million
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $1.72 Million - $2.06 Million	35,522 New	35,522 $1.78 Million

Others Institutions Holding AZN

# of Institutions

1,449

Shares Held

489M

Call Options Held

7.22M

Put Options Held

2.57M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $255B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Family Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Family Advisors, LLC with notifications on news.

Account

Oak Family Advisors, LLC Astrazeneca PLC Transaction History